Because of a close association between platelets and macrophages in early fatty streak lesions, the hypothesis was tested that platelets contribute to lesion progression by directly enhancing macrophage cholesteryl ester (CE) 
Introduction
Large numbers of lipid-laden macrophages are the hallmark of early fatty streak lesions (1) (2) (3) . The mechanisms whereby lipids are sequestered by these cells are not fully understood. Studies of the interaction of plasma-derived lipoproteins with macrophages are pertinent to foam cell formation in areas where the endothelium is intact. However, in areas of endothelial cell injury, other factors may contribute to or accelerate foam cell formation as well. A close association between platelets and monocytes has been documented in areas of endothelial denudation, and this association could enhance macrophage accumulation of cholesteryl esters (CE)' (1) (2) (3) (4) . As early as 1961
Chandler and Hand (5) suggested that the phagocytosis oflipidrich platelets by macrophages could be a contributing factor to the lipid accumulation observed in foam cells of the more advanced atherosclerotic lesion. Recent studies suggest that activated platelets can contribute at least qualitatively to CE accumulation in smooth muscle cells (6) and macrophages (7) .
In this report we demonstrate that platelets enhance both the rate of CE formation and the total CE accumulation in culThis is publication No. 4646-IMM from the Dept. of Immunology of the Scripps Clinic.
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1. Abbreviations used in this paper: aLDL, acetylated low density lipoprotein; apo E, apoprotein E; CE, cholesteryl esters; PBM, peripheral blood mononuclear cells; RBC, red blood cells.
tured peripheral blood mononuclear cell (PBM)-derived macrophages. Furthermore, we demonstrate that the capacity of platelets to enhance CE accumulation is a saturable and specific process and can be induced by products released from activated platelets. It is thus hypothesized that platelets, which accumulate and are activated at sites of vessel wall damage, can enhance the conversion of monocytes into foam cells and thus contribute to the progression of the fatty streak lesion.
Methods
Lipoproteins. Low density lipoprotein (LDL) was isolated from plasma of normal fasting subjects by sequential ultracentrifugation using KBr for density adjustment as previously described (8) . The LDL was dialyzed against 0.15 M NaCl, 0.3 mM EDTA, 5 mM benzamidine, and 0.0005% alpha-tocopherol, pH 7.4, filter sterilized and stored at 4VC. Protein and cholesterol were measured by a modification of the method of Lowry using a bovine serum albumin (BSA) standard (9) and by an enzymatic fluorometric assay (10, 1 1), respectively (see below). Apoprotein composition of the lipoproteins was assessed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (8) . Acetylated LDL, modified by treatment of isolated LDL with acetic anhydride, was prepared as described by Basu et al. (12) . Acetylation was verified immunochemically with acetyllysine-specific antibodies as described (13).
Isolation ofplatelets. Platelets were isolated by differential centrifugation from fresh human blood drawn into 5 U/ml of heparin (14). The heparinized blood was centrifuged at 800 g for 15 min at 230C to recover a platelet-rich plasma (PRP) fraction. To minimize platelet activation, prostaglandin El and theophylline (Sigma Chemical Co., St. Louis, MO) were added to the PRP at final concentrations of 1 Jg/ml and 1 mM, respectively. When necessary, the PRP was stored at 220C. The platelets were isolated from PRP by centrifugation at 1,000 g for 20 min, were resuspended in divalent ion free-Tyrode's buffer and washed twice. After the final wash the platelets were resuspended in RPMI 1640, which contained 1% nutridoma-HU (Boehringer Mannhein Biochemicals, Indianapolis, IN). Platelet supernatants were prepared by activating platelets that were suspended in RPMI 1640 containing 1% nutridoma-HU at I09 cells/ml, with thrombin at 1 U/ml in the presence of 1 mM CaCI2. After 3 h at 37°C platelet pellets and platelet supernatants were recovered by centrifugation at 1,000 g for 20 min. When necessary, the platelet supernatants were stored at 4°C. Platelet protein and cholesterol were measured as described above. When platelet serotonin secretion was measured, the platelets were prelabeled with 5-hydroxy[G-3H]tryptamine creatinine sulfate and its secretion assayed in the presence of 2 MM imipramine as described (15). The secretion of platelet beta thromboglobulin was assayed with an immunoassay kit supplied by Amersham Corp. (Arlington Heights, IL). For these analyses, the platelet supernatants were collected by centrifugation of the cell suspension for 3 min in a Beckman microfuge.
Isolation ofPBM and red blood cells (RBC). PBM were isolated from heparinized blood by differential centrifugation (16) . After removal of the PRP, the cell pellet was resuspended to two times its original volume in RPMI 1640 that contained 10 mM Hepes, 2 mM glutamine, 0.05 mg/ml gentamicin, and 1 mM sodium pyruvate. The resuspended cells were layered onto Ficoll-Hypaque and centrifuged at 1,000 g for 20 min. Cells at the interface were removed, washed, and resuspended in RPMI 1640 that contained 1% Nutridoma-HU. The PBM cells were adjusted to a concentration of 5 X 106/ml, and 1.0-ml cultures established in 12-well, 22-mm diam plastic culture plates. After incubation at 37°C for 24 h, nonadherent cells were removed by washing the wells three times and the adherent cells fed again with RPMI 1640 that contained 1% nutridoma-HU. This adherent cell population contained > 96% esterasepositive cells and represented between 5 and 15% of the 5 X 106 PBM. Platelet contamination as assessed visually averaged between zero and four platelets per adherent cell. The adherent cells were cultured at a final volume of 1.0 ml in the presence of added lipoproteins or platelets as indicated.
RBC were obtained from the Ficoll-Hypaque pellet and washed repeatedly in RPMI 1640. RBC ghosts were obtained by lysing the cells in H20 and recovering the ghosts by centrifuigation at 39,200 g. A portion of the RBC ghosts also were sonicated for 10 min at 20 W in RPMI 1640. Visual inspection of the sonicate revealed the absence of intact ghosts. A comparison of the size of the sonicated RBC ghosts, as monitored by the presence of free cholesterol, indicated that > 70% of the cholesterol could be passed through a 0.45 Am sterile filter, but 99% was retained on a XM300 Diaflo ultrafiltration membrane (Amicon Corp., Lexington, MA) consistent with a molecular weight of the sonicated ghosts exceeding 300,000. Furthermore, the cholesterol associated with the sonicates eluted in the void volume of a Sepharose CL-2B column (Pharmacia Fine Chemicals, Piscataway, NJ). Opsonized RBC were prepared by incubating the cells with an optimum concentration of rabbit anti-erythrocyte antibody. Binding of the opsonized RBC to the monocytes was verified by light microscopy. Most macrophages contained > 10 adherent RBC.
Cell harvest. 2 [3H]oleate had a specific activity of25 mCi/mM and was added as a 4.5: 1 (oleate/albumin) molar complex. The cells were harvested by transferring the supernatants to 1.2-ml microfuge tubes (Brinkman Instruments Inc., Westbury, NY) that were spun at 8,000 g for 2.5 min in a Beckman Microfuge II. The clarified supernatants were stored at -20'C for assay of apoprotein E (apo E) by radioimmunoassay as described below. The adherent cells were washed twice with cold phosphate-buffered saline and extracted with 1 ml ofabsolute ethanol. The cells were scraped from the wells and added to the original cell debris recovered above, and were pelleted by centrifugation at 8,000 g for 2.5 min in a microfuge. The soluble ethanol extracts were transferred to 12 X 75-mm glass tubes and evaporated to dryness in a Speedvac concentrator (Savant Instruments Inc., Hicksville, NY) for counting and for assay of cholesterol. The cells and debris recovered in the pellets were retained for assay of DNA as described below. Although only the macrophages contained detectable amounts of either CE or DNA, this harvesting procedure resulted in the collection of all adherent or nonadherent cells and debris (platelet, RBC, and macrophage) for subsequent assay.
Apo E secretion. Apo E in the culture medium was assayed immunochemically in a sensitive competitive solid-phase radioimmunoassay. Microtiter plates were precoated with 0.1 ml of protein A at 500 ng/ml in borate-buffered saline and then coated with the apo E-specific monoclonal antibody, lE (17) . The IE antibody is an IgG2a k antibody, which was generated from the fusion of P3.Ag8.653. 1 myeloma cells with the spleen cells of a BALB/c mouse immunized with isolated apo E. All antibodies, competitors, and standards were diluted with borate-buffered saline that contained 3% BSA and 4 mM N-octyl-beta-D-glucopyranoside. Monocyte culture supernatants or standards (0.1 ml) were added to the antibody-coated wells. The plates were incubated at 40C for 18 h and washed extensively. Apo E was quantitated with a second 3-h incubation at 40C with 0.1 ml of '25l-apo E. Apo E was radioiodinated to specific activities of 7-12 uCi/,ug as described (18) and 200,000 cpm added per well. A specificity control was included in each assay in which an irrelevant antibody ofthe same heavy chain class was substituted for IE. Data was expressed as B/Bo, with B representing the amount bound in the presence and Bo the amount bound in the absence of competitors. The apo E standard was isolated as described (18) and its protein content was estimated with the modified Lowry assay (9).
CEformation and accumulation. Cholesterol esterification was measured as incorporation of [3Hfoleate into CE during the final 2 h of culture. CE in ethanol extracts of cells were separated by chromatography on disposable aminopropyl bonded-phase columns (Bond Elute; Analytichem International, Harbor City, CA) as described (19) . For chromatography the dried ethanol extracts were resuspended in 1.5 ml of hexane and applied to the column. CE were eluted under vacuum with 4 ml of hexane. The free cholesterol retained on the column was eluted with 20 ml of 15% ethyl acetate. The separate hexane and ethyl acetate extracts were dried in the presence of N2, were resuspended in 0.2 ml ofabsolute ethanol, and 0.015-ml aliquots were transferred to glass tubes for measurement of total cholesterol as described below. The remaining 0.1 ml was counted in the presence of 4 ml of 3a20 ( 
Results
The capacity ofplatelets to enhance CE accumulation in cultured human macrophages was first observed in experiments performed to identify factors that could increase the production and secretion of apo E. Peripheral blood mononuclear adherent cells were cultured for 6 d in serum-free medium in the presence of a variety of factors including: 100 ,ug/ml of LDL, 100 ,ug/ml of acetylated LDL (aLDL), 360 jg/ml of urate crystals, 10 ug/ ml of lipopolysaccharide (LPS), and 10'/ml of isolated autologous platelets (Fig. 1) . As reported previously for mouse peritoneal macrophages and human monocyte-derived macrophages (12, 21, 22) , aLDL enhanced the production and secretion of apo E by these cultured cells (Fig. 1 A) . However, the increase in apo E production induced by the culture of macrophages in the presence of platelets exceeded that obtained with aLDL. In these same cells, stimuli such as urate crystals or LPS reduced apo E production below control levels obtained with only medium.
To determine if the enhancement of apo E production observed with platelets was a reflection oftheir capacity to increase CE accumulation in these cells, the macrophages were extracted into ethanol and the total amount of accumulated CE was measured ( Fig. 1 B) . The (Fig. 2) . This suggested that stimulation was not required when resuspended platelets or platelet pellets (debris) were used. However, differences were observed between unstimulated and thrombinstimulated platelets when only the l,000-g supernatants were added to the macrophage cultures. The supernatants of stimulated platelets enhanced CE accumulation, whereas the supernatants of unstimulated platelets were not active. Thus, only thrombin-stimulated platelets released a substance(s) that enhanced cholesterol esterification (Fig. 2) , but either stimulated or unstimulated platelet pellets were active by themselves.
To determine if the capacity of platelets to enhance CE accumulation in cultured macrophages was specific to platelets, RBC were tested for their capacity to facilitate CE accumulation. The capacity of 109 platelets to enhance CE accumulation was compared with the capacity of 109 RBC or RBC ghosts (Fig. 3) .
Only platelets were capable of facilitating cholesterol loading of these cells despite the fact that comparable amounts of free cholesterol were added to the macrophages with each cell type. In additional studies it was determined that 109 RBC opsonized with rabbit antibody or sonicated RBC ghosts were devoid of activity as well ( be filtered through a 0.45-Mm sterile filter but were retained on a 300,000-Mr membrane filter. Similarly, the cholesterol ofeither fraction was recovered in the void volume of a Sepharose CL-2B molecular sieve column, suggesting that the cholesterol-rich vesicles were very large.
To further characterize the effect ofplatelets on macrophage CE accumulation, we measured the kinetics of oleate incorporation into cholesteryl oleate as well as the total mass of cellular CE. (Fig. 4 A) . These changes in the rate of cholesteryl
[3H]oleate formation were reflected in similar measurements of total CE accumulation. Within 2 d, > 100 ng ofCE were detected per microgram ofcellular DNA. This accumulation was maximal by day 3 and was maintained for at least 6 d of culture (Fig. 4  B) . Therefore, cells cultured in serum-free medium in the presence of platelets demonstrated a dramatic increase in the rate of cholesterol esterification, which was reflected also in a large increase in the CE content of these cells. Furthermore, by day 3 of culture morphologic examination of these platelet-cultured cells by light microscopy demonstrated the presence ofnumerous lipid droplets that were easily visualized in virtually all macrophages, giving them the appearance of typical foam cells. Most of the macrophages also had platelets adhering to their surface.
To determine the optimum number of platelets for macrophage cholesterol loading, increasing numbers of platelets were added to 1.0-ml cultures that contained 5 X 10 adherent cells. After 48 h both the rate of cholesterol esterification and the total amount of accumulated CE were measured (Fig. 5) . Maximum rates of [3H]oleate incorporation into cholesteryl oleate were obtained with 2.5-5 X 108 platelets/ml, and minimal rates were obtained with < 2 X 107 or > 2 X 109 platelets/ml. Similar relationships were observed when the CE mass was measured after 48 h of culture. Maximal CE accumulation was observed with 5 X 108 platelets/ml and was minimal at < 2 X I07 or > 2 X 109/ml.
To more carefully characterize the supernatants ofthrombinstimulated platelets that induced CE formation (Fig. 2) , isolated platelets were adjusted to a concentration of 109/ml in Tyrode's buffer and exposed to a-thrombin. At varying times the reaction mixtures were spun at 10,000 g for 3 min in a Beckman microfuge and the supernatants monitored for their capacity to induce macrophage GE accumulation. As shown in Fig. 6 , the biologic activity ofthe platelet supernatants (as assessed by their capacity to induce CE accumulation in cultured macrophages assayed on day 3) increased between 0 and 60 min after platelet stimulation. The platelet supernatants obtained after 30 min of thrombin stimulation induced the accumulation on day 3 of 124±12 ng ofesterified cholesterol per microgram ofmacrophage DNA compared with the platelet supernatants obtained after 10 min of thrombin stimulation. These 10-min supernatants induced the accumulation on day 3 of only 34±15 ng of esterified cholesterol per microgram of macrophage DNA.
This time scale for release of biologic activity appeared to be prolonged relative to the platelet secretory reaction. Therefore, these same platelet supernatants were monitored for specific platelet constituents including serotonin, a platelet dense granule marker, f,-thromboglobulin, an alpha granule marker, as well as for free cholesterol, a membrane marker. Thrombin-induced Figure 6 . Macrophage CE accumulation by thrombin-stimulated platelet supernatants:correlation with platelet-free cholesterol. Isolated platelets were adjusted to 109/ml in RPMI 1640. The platelets were incubated at 370C in the presence of 1 U/ml of a-thrombin plus 1 mM CaCl2. At the times indicated the reaction mixtures were centrifuged at 10,000 g for 3 min, and the supernatants collected for assay of serotonin, f-thromboglobulin, free cholesterol, and biological activity. For estimates of percent release for serotonin, fl-thromboglobulin, and cholesterol (solid lines), maximum release was taken as the value at 60
min. For serotonin and P-thromboglobulin this represented 2 95% of the total platelet content of these constituents. For cholesterol this represented only 16% of the total platelet cholesterol; however, the amount released at 60 min appeared to represent 100% of the maximum releasable cholesterol because the 120-min supernatants also contained only 16% of the total platelet cholesterol. Biological activity expressed as percent of maximum (dashed line) was measured by assaying the capacity of the supernatants to induce the accumulation of CE. The adherent cells from 5 X 106 PBM were cultured for 3 d in the presence of 1 ml of platelet supernatant. Maximnum biological activity was taken also as the value at 60 min, which was 135±22 ng CE/Mg of macrophage DNA.
serotonin and f3-thromboglobulin secretion were 2 90% complete by 10 min, whereas the recovery of cholesterol was . 30% of the maximum response by 10 min. This suggested that the released cholesterol was not a typical platelet dense granule or a-granule secretion product. More importantly, only the platelet supernatants that contained cholesterol were capable of enhancing macrophage accumulation of CE, and a direct correlation was found between the biologic activity of platelet supernatants and their content of free cholesterol (r = 0.98).
To verify that the enhanced estenfication rates and CE accumulation observed in platelet-exposed macrophages did not reflect just differences in cellular rates of protein synthesis, a biologically inactive 5-min platelet supernatant was compared with a biologically active 3-h platelet supernatant for their capacity to support cellular protein synthesis. Protein synthesis was assessed by measuring the incorporation of [3H]leucine into TCA precipitable radioactivity. After a 2-h pulse with
[3H]leucine, macrophages cultured for 24 h with 5 X 108 platelets, the 5-min supernatants from I09 thrombin-stimulated platelets, or the 3-h supernatants of thrombin-stimulated platelets contained 1,508±35, 1,457±116, and 1,802±78 TCA precipitable counts per microgram DNA, respectively. In additional experiments, no differences were observed in the rates ofprotein synthesis in macrophages cultured with platelets or sonicated RBC ghosts, although again large differences were observed in the capacity of the platelets or RBC to induce CE accumulation (Table I) . The results provided additional evidence that platelets and/or substances released by activated platelets specifically enhanced macrophage CE accumulation.
Discussion
Our understanding of the role macrophages play in cholesterol metabolism has increased significantly over the past few years. Macrophages can take up and degrade numerous cholesterolcontaining substances including cell debris and plasma lipoproteins. A great deal ofwork has been done to describe the capacity of macrophages to bind and degrade specifically modified or cholesterol-rich lipoproteins (23) . The cellular uptake of these lipoproteins leads to the hydrolysis of lysosomal CE that results in the release of intracellular free cholesterol, which is esterified by the microsomal acyl-CoA:cholesterol acyltransferase (ACAT) system and stored internally as lipid droplets. Macrophages that contain large amounts of stored CE also increase their synthesis of a specific apolipoprotein, apo E (12) . In our studies of factors that influenced the production of apo E by cultured human monocytes, different means of loading the cells with CE were sought. As expected, the modified lipoprotein, aLDL, enhanced CE storage and stimulated an increase in apo E production. As described by Kayden et al. (22) , native LDL was active as well, although the degree of CE accumulation and subsequent apo E production was considerably less. Similarly, it was reported that apo E production is decreased (24) when monocyte/macrophages are cultured in the presence of specific stimuli such as endotoxin. These observations were confirmed here, where it was demonstrated that LPS and urate crystals inhibited both CE accumulation and apo E production. To provide another source ofcholesterol for macrophage CE accumulation, autologous unstimulated platelets were added to the cultured macrophages. The result was a striking increase in macrophage CE to a level that exceeded the level obtained with acetylated LDL. Although "foam cell formation" typically implies that the intracellular ratio of esterified cholesterol to free cholesterol approaches or exceeds > 50% oftotal cellular cholesterol, this ratio could not be accurately measured in these studies because of the contribution of the activated platelets (or opsonized RBC) to the free cholesterol content of the harvested cells. Upon microscopic examination, a close association was always observed between the activated platelet (or opsonized RBC) and macrophages, indicating that the estimates of macrophage free cholesterol and protein reflected platelet-associated free cholesterol and protein as well. Therefore, all of these studies report only rates ofcholesterol esterification or CE mass and were corrected for cell recovery on the basis of DNA rather than protein. (25) , and this could imply that specific adhesive proteins and their receptors facilitate this interaction.
The requirement for platelet activation also was investigated. In early experiments no specific platelet stimuli were used. Because no particular precautions were taken in these experiments to prevent platelet stimulation, it is highly probable that the platelets were activated. When a specific requirement for platelet stimulation was investigated, it was found. That is, the supernatants of unstimulated platelets were not active, whereas the supernatants from thrombin-stimulated platelets were active. Because only platelet supernatants that contained cholesterol were active, it implies that free cholesterol may be required for activity. However, at this point only a correlation exists between free cholesterol and activity and requirements for other factors or substances cannot be ruled out. The observation that cholesterol-containing sonicates of RBC ghosts were not active suggests that if free cholesterol is involved, its association with other platelet constituents may be crucial for its activity.
As shown in Fig. 5 , declines in both the formation and mass of CE were observed with high concentrations of platelets. Because the cell recovery as assessed by the recovery of DNA was the same in cultures containing large numbers ofplatelets, other explanations must be sought for the decline in activity. Perhaps factors that competitively inhibit CE accumulation were produced at the higher platelet concentrations. These inhibitory factors could be related to the platelet secretory factors described recently by Phillips et al. (26) . These investigators reported that the supernatants of thrombin-stimulated platelets inhibited macrophage CE accumulation that resulted from culture in the presence ofaLDL. It was concluded that the platelet supernatants contained a substance(s) that competitively inhibited the binding of aLDL to the macrophage scavenger receptor. The possibility exists that larger amounts ofthese substances could also interfere with the interaction of platelets and macrophages and result in inhibition of platelet-induced CE accumulation. However, preliminary experiments aimed directly at the role of macrophage lipoprotein receptors, including both the LDL receptor and the scavenger receptor, have not implicated either receptor in platelet-induced CE accumulation. The inclusion of heparin, dextran sulfate, fucoidin, and polyinosinic acid either separately or in combination at concentrations at which they have been demonstrated to prevent either LDL receptor or scavenger receptor binding (27) did not interfere with platelet-induced increases in cholesterol esterification, suggesting that these receptors are not involved. However, further studies are necessary to completely rule out the lipoprotein receptors and to identify the cause of the decline in activity observed with high platelet numbers.
What is the implication of this in vitro phenomenon for the pathogenesis ofatherosclerosis and foam cell formation in vivo? Evidence that progression of an atherosclerotic lesion is related to the integrity of platelet function comes from multiple sources. Harker and colleagues (28) induced vessel wall intimal lesions with homocysteine in baboons and showed that dipyridamole, an agent that inhibits platelet reactions, was able to inhibit the proliferative response and prevent the formation of lesions. Moore et al. (29) induced thrombocytopenia in rabbits and demonstrated that in the absence of circulating platelets no lesions developed in response to physical injury ofthe vessel wall. Von Willebrand factor is required for platelet adhesion, and hypercholesterolemic pigs with homozygous deficiency of this factor have been reported to develop fewer lesions than normal pigs fed the same high cholesterol diet (30) . More recently, aspirin therapy has been shown to decrease both macroscopic and microscopic experimental atherosclerosis in dogs (31) .
Morphologic studies by Gerrity (1) and Faggiotto and Ross (2, 3) to track the development of lesions of atherosclerosis resulting from hypercholesterolemia in swine and in nonhuman primates suggests that after adherence and subendothelial migration ofblood-derived monocytes, changes in the luminal surface of the artery lead to the loss of endothelial cells. A striking feature ofthis more advanced proliferative lesion is the presence of large numbers of spread platelets or platelet micro-particles adhering to the subendothelium, and particularly those in intimate and close contact with macrophages. After exposure ofthe subendothelium, a series of events take place including adhesion and aggregation of platelets and platelet granule secretion. These series ofevents mobilize monocyte-derived macrophages, which then ingest the cholesterol-bearing platelet debris. Platelet antigens are easily detected in the foam cells of atherosclerotic lesions (4) . Such a close association between activated platelets containing large amounts of free cholesterol and monocytes could lead to massive CE accumulation and perpetuation of endothelial cell damage and progression of an atherosclerotic lesion. Thus, we hypothesize that platelets enhance foam cell formation after damage to the endothelium, and thus can contribute to progression of the fatty streak lesion.
